Articles by Daniel Marsh
Lilly Surges on EU Leukemia Drug Approval; Pre-Market Nears Analyst Target
Eli Lilly shares jumped 7.13% to a record $1,208.12 Friday, adding $75.7B in market cap after EU regulators recommended Jaypirca for chronic lymphocytic leukemia.
Apple Stock Steady Amid $100 Billion Buyback and DRAM Policy Risks
Apple shares held steady near $284 after a 3.14% Friday surge, as a $100 billion buyback plan offsets rising DRAM costs and policy risks from a potential CXMT deal.
South Korea's $518B Chip Plan Fails to Impress Investors
South Korea's revised 800 trillion won ($518.3B) chip plan, down 60% from earlier estimates, sent Samsung down 4.86% and SK Hynix down 1.68% as investors focused on capex load.
SpaceX Launches SiriusXM Satellite, Shifting Focus to Service Timeline
SpaceX launched SiriusXM's SXM-11 satellite, eliminating launch risk. The market's attention now turns to how quickly the satellite begins service, with the 74-day SXM-10 benchmark in focus.
NASA Awards $30M Satellite Boost Contract; SpaceX Launches Sirius XM Satellite
NASA contracts Katalyst Space for a satellite boost mission, SpaceX launches SXM-11 for Sirius XM, oil prices rise on Hormuz tanker imbalances, and Lazard offers a high dividend yield amid financial concerns.
Federal Loan Caps Shift Grad Students to Private Lenders
Starting July 1, new caps on federal Grad PLUS loans will force many graduate and professional students to seek private financing, potentially boosting originations at Sallie Mae and SoFi.
IREN Stock Drops 21% Despite Record Warriors Jersey Deal
IREN shares plunged 21.3% to $47.21 over five sessions despite a record $50M+ Warriors jersey deal, as short interest hit 19.74% and the $4.4B target ARR remains largely uncontracted.
Cisco's Heavy Trading Volume Drives 90% of Weekly Drop Ahead of Holiday
Cisco dropped 4.37% to $113.77 on Friday, erasing $21 billion in market value on volume 2.3 times the average, as the stock tracked AI-linked peers despite strong Q3 results and raised AI order targets.
Kroger's Private Label Scrutiny Rises After USDA Chicken Alert
A USDA alert flagged mislabeled Private Selection chicken at Kroger in nine states, but no adverse reactions were reported. The stock closed Friday at $57.73.